Black Maple Capital Management LP 89bio, Inc. Transaction History
Black Maple Capital Management LP
- $206 Billion
- Q3 2025
A detailed history of Black Maple Capital Management LP transactions in 89bio, Inc. stock. As of the latest transaction made, Black Maple Capital Management LP holds 321,616 shares of ETNB stock, worth $4.77 Million. This represents 2.29% of its overall portfolio holdings.
Number of Shares
321,616Holding current value
$4.77 Million% of portfolio
2.29%Shares
1 transactions
Others Institutions Holding ETNB
# of Institutions
234Shares Held
156MCall Options Held
710KPut Options Held
6.17M-
Ra Capital Management, L.P. Boston, MA19.9MShares$295 Million5.01% of portfolio
-
Pentwater Capital Management LP Naples, FL11.8MShares$174 Million1.08% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.36MShares$139 Million4.33% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.1MShares$135 Million0.22% of portfolio
-
Suvretta Capital Management, LLC New York, NY8.28MShares$123 Million3.65% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $690M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...